scPharmaceuticals Inc. (NASDAQ: SCPH) reported Q4 EPS of ($0.35), $0.03 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $12.15 million versus the consensus estimate of $12.13 million.

For earnings history and earnings-related data on scPharmaceuticals Inc. (SCPH) click here.